problems and confusing symptoms are not always easy to resolve. The
human body usually does not reveal its deficiencies with superficial
investigations. Lab tests to pinpoint the contributing causes of
symptoms and disease are not commonly performed by conventional
Dr. Bronner is an expert in
functional medical testing. If necessary Dr. Bronner can order any lab or diagnostic test that is currently
available. The following are some of the tests
available to his patients.
AMAS Cancer Testing - AMAS stands for "anti-malignin antibody in serum." The AMAS Cancer test is an innovative test that is based on levels
of a specific antibody, shown to be elevated in a wide range of cancer
types. This makes it different from most cancer tests which generally
measure levels of an antigen associated with a particular cancer type.
The AMAS test is
extremely sensitive; blood levels of this antibody rise early in the
course of the vast majority of cancers of all types, regardless of
location in the body. The test is especially useful when cancer is
suspected but has not been confirmed by a biopsy.
The AMAS test also is useful in monitoring the treatment of
malignancies. Levels typically return to normal within two to three
months of successful treatment. Other biological markers in the blood
are much less specific and are usually not elevated early in the course
of disease or recurrence. Thus the AMAS test is an excellent way to
screen for and detect cancer or recurrences, and to track treatment
progress during treatment.
Conventional cancer treatment authorities
are committed to a host of expensive and highly profitable diagnostic techniques (mammograms, MRIs, gastrointestinal series,
etc.). Were it not for the intransigence of established authorities,
the AMAS test undoubtedly would be much more widely used.
The AMAS test should be ordered and interpreted by a physician
experienced with the test. False negatives and positives do occur.
Profile - analyzes eleven saliva samples over a 28-day period for
the levels of ß-estradiol, progesterone, and testosterone,
providing clues about menstrual irregularities, infertility,
endometriosis, breast cancer, and osteoporosis.
Assessments - evaluate how estrogen is being
processed in the body.
- Menopause Profile
- examines three salivary samples over a 5-day period to determine
levels of ß-estradiol, estriol, estrone, progesterone, and
testosterone for women who are menopausal.
Male Hormone Profile - analyzes four saliva samples over a 24-hour period for levels of
testosterone, free testosterone, melatonin, and the estrogens.
Comprehensive Thyroid Assessment - a comprehensive analysis of thyroid hormone
secretion and metabolism, including central thyroid regulation and
activity, peripheral thyroid function, and thyroid autoimmunity.
Assessment - a simple, direct urinary assay of pyridinium
crosslinks and deoxypyridinoline, useful in identifying current
rate of bone loss, lytic bone disease, and efficacy of bone
Tolerance Test - employs a glucose challenge and blood samples over
a four-hour period to assess the relationship of insulin and
Profile - is a salivary assay of cortisol and DHEA, imbalances of
which are associated with ailments ranging from obesity and
menstrual disorders to immune deficiency and increased risk of
Melatonin Profile - analyzes three saliva samples for the secretion
pattern of this important hormone.
- IGF-1 (Insulin-like
Growth Factor-1 or Somatomedin C) - mediates many of the in
vivo cell division and metabolic effects of growth
Digestive Stool Analysis - evaluates digestion and absorption,
bacterial balance and metabolism, parasite infection, yeast and
Parasitology Profile - evaluates stool for presence of parasites and
levels of beneficial flora, imbalanced flora, pathogenic bacteria,
Permeability Assessment - analyzes urine for the clearance of two
non-metabolized sugars, lactulose and mannitol. Identifies "leaky
gut" and malabsorption.
Stool Antigen Test - an FDA-approved evaluation of H. pylori
antigens shed directly in the stool. This test is useful for
detecting the major causal bacterium associated with peptic
ulcers, chronic gastritis, and increased risk of gastric cancer.
This noninvasive test also provides a simple and sensitive
clinical tool for monitoring eradication therapy.
Clearance Profile (24 hr and Random/Timed) - measures urinary
excretion of 9 nutrient elements and 20 toxic metals, including
"classic" toxics such as lead, mercury, and arsenic, as well as
newer technology toxics such as niobium and
Profile - evaluates fourteen organic acids that play a pivotal role
in the generation of cell energy. Using a urine sample, the test
can reveal metabolic distress associated with generalized pain and
fatigue, which may arise in response to toxic exposure, nutrient
imbalances, digestive dysfunction, and other causes
Detoxification Profile - analyzes saliva, blood, and after-
challenge doses of caffeine, aspirin, and acetaminophen in order
to assess the Phase I and Phase II functional capacity of the
liver to convert and clear toxic substances from the body. This
profile includes markers for oxidative stress and important
Analysis - identifies markers of hydroxyl
radical activity, urine lipid peroxides, reduced glutathione,
superoxide dismutase, and glutathione peroxidase, following a
challenge dose of aspirin and acetaminophen.
Cardiovascular Profile - analyzes blood for levels of HDL, LDL,
lipid fractionation, total cholesterol, ratios, triglycerides,
lipoprotein(a), homocysteine, fibrinogen, and high-sensitivity
C-reactive protein. Includes Relative Risk Indices and Metabolic
- SpectraCell FIA 5000 - measures
how micronutrients are actually functioning within your patients’ white
blood cells. These tests allow nutritional assessment of your patients
for a broad variety of clinical conditions including arthritis, cancer,
cardiovascular risk, diabetes, various immunological disorders,
metabolism disorders and micronutrient deficiencies.
Our predictive genomic profiles assess
genetic variations in each person that, when combined with
modifiable factors in the environment, may increase disease risk.
This empowers physicians and patients to realize earlier, more
effective preventive interventions-years before disease
develops. It also enables precise, customized
therapies that truly address each individual's need, and improved clinical
insight into patients with treatment-resistant "chronic"
- identifies genetic single nucleotide polymorphisms associated with
increased risk of developing atherosclerosis, hypertension, and
coronary artery disease. Risk factors include methylation defects,
hyper-coagulation syndromes, cholesterol regulation defects,
inflammation, general risk markers and cardio-protective
- identifies genetic single nucleotide polymorphisms associated with
increased risk of developing osteopenia and osteoporosis. Risk
factors include collagen synthesis, calcium metabolism, vitamin D3
activity, parathyroid hormone action, osteoclastic activity, and
DetoxiGenomic™Profile - identifies genetic single nucleotide
polymorphisms associated with increased risk of developing
detoxification defects especially with increased exposure to
xenobiotics and other toxins. Risk factors include altered
cytochrome P-450 activity in phase 1 detoxification, impaired
glutathione conjugation and acetylation in phase 2 reactions,
altered catecholamine methylation and increased oxidative stress.
Detoxification defects have been associated with increased risk
for certain cancers, chronic fatigue, multiple chemical
sensitivity, and alcoholism.
ImmunoGenomic™Profile - identifies
genetic single nucleotide polymorphisms associated with increased
risk of developing defects in immune competence and surveillance.
Risk factors include altered interleukin production and activity
within the body and increased production of other cytokines like
tissue necrosis factor alpha that may lead to conditions
characterized by chronically up-regulated inflammatory response.
Immunologic polymorphisms have been associated with increased risk
of asthma, atopy, osteopenia, heart disease, and infectious
Bronner can provide access to all diagnostic imaging
services such as radiology, CAT, PET, MRI and Ultrasound.
- Bioelectrical Impedance Analysis - considered one of the most exact and accessible methods of screening
body fat. In conventional BIA, a person is weighed, then height,
age and gender are entered in a computer. While the person is lying
down, electrodes are attached to various parts of the body and a
small electric signal is discharged that measures the impedance or
resistance to muscle and fat. The more muscle, the lower the value,
as the electricity passes easily through lean mass. A formula in the
computer converts all of the data to indicate what percentage of the
body is fat.
- Carotid Intima Media (CIMT) Testing - uses ultrasound to identify the early and intermediate stages of atherosclerosis, even if you show no outward signs or
symptoms of the disease. Also measures the degree of
inflammation in the arterial wall or the size of the plaque that may
contribute to heart